Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 6/20 | 0.47 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.46 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.38 |
| ▸ | APP | P05067 | 2/20 | 0.38 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.36 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.36 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8617758 | 1.00 | ACHE (0.47) | ACHEGPR84FFAR1FFAR4ALDH1A1 | |
| SCHEMBL1505795 | 1.00 | ACHE (0.47) | ACHEGPR84FFAR1FFAR4ALDH1A1 | |
| SCHEMBL27575500 | 1.00 | ACHE (0.47) | ACHEGPR84FFAR1FFAR4ALDH1A1 | |
| SCHEMBL8621718 | 1.00 | ACHE (0.47) | ACHEGPR84FFAR1FFAR4ALDH1A1 | |
| SCHEMBL575111 | 1.00 | ACHE (0.47) | ACHEGPR84FFAR1FFAR4ALDH1A1 | |
| SCHEMBL29013659 | 1.00 | ACHE (0.47) | ACHEGPR84FFAR1FFAR4ALDH1A1 | |
| SCHEMBL628079 | 1.00 | ACHE (0.47) | ACHEGPR84FFAR1FFAR4ALDH1A1 | |
| SCHEMBL29244356 | 0.97 | ACHE (0.46) | ACHEGPR84FFAR1FFAR4ALDH1A1 | |
| Ethylene Glycol SCHEMBL7939434 | 0.97 | ACHE (0.46) | ACHEGPR84FFAR1FFAR4ALDH1A1 | |
| SCHEMBL575104 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110407991-B | Multi-block copolymer based on 2, 5-furandicarboxylic acid polyester and aliphatic polycarbonate and preparation method thereof | 浙江大学 | 2020-07-17 | — | — | CN | claimed |
| CN-110407991-A | A kind of segmented copolymer and preparation method thereof based on 2,5- furandicarboxylic acid polyester and fatty poly-ester carbonate | UNIV ZHEJIANG | 2019-11-05 | — | — | CN | claimed |
| EP-4707347-A1 | PRINTING INK, METHOD FOR PRODUCING PRINTED MATERIAL, AND PRINTED MATERIAL | Spiber Inc. (JP) | 2026-03-11 | — | — | EP | disclosed |
| EP-4653449-A1 | METHOD FOR PRODUCING BLOCK COPOLYMER OR AQUEOUS DISPERSION CONTAINING SAME, ADHESIVE, COATING LIQUID, COATING AGENT, OR MOLDED BODY | Spiber Inc. (JP) | 2025-11-26 | — | — | EP | disclosed |
| US-20250163112-A1 | Porous Body and Method for Producing Same | SPIBER INC. (JP) | 2025-05-22 | — | — | US | disclosed |
| US-20250075423-A1 | ARTIFICIAL LEATHER AND METHOD FOR PRODUCING SAME | SPIBER INC. (JP) | 2025-03-06 | — | — | US | disclosed |
| EP-4382661-A1 | ARTIFICIAL LEATHER AND METHOD FOR PRODUCING SAME | Spiber Inc. (JP) | 2024-06-12 | — | — | EP | disclosed |
| EP-4382532-A1 | POROUS BODY AND METHOD FOR PRODUCING SAME | Spiber Inc. (JP) | 2024-06-12 | — | — | EP | disclosed |
| US-20230128695-A1 | Synthetic Polymer and Method for Producing Same, Molding Material, and Molded Body | SPIBER INC. (JP) | 2023-04-27 | — | — | US | disclosed |
| EP-4122948-A1 | SYNTHETIC POLYMER AND METHOD FOR PRODUCING SAME, MOLDING MATERIAL, AND MOLDED BODY | Spiber Inc. (JP) | 2023-01-25 | — | — | EP | disclosed |
| CN-110407991-A | A kind of segmented copolymer and preparation method thereof based on 2,5- furandicarboxylic acid polyester and fatty poly-ester carbonate | UNIV ZHEJIANG | 2019-11-05 | — | — | CN | disclosed |
| CN-109585910-A | A kind of solid union electrolyte and its dielectric film preparation method and application | 吉林师范大学 | 2019-04-05 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250075423-A1 | ARTIFICIAL LEATHER AND METHOD FOR PRODUCING SAME | PLOD3, FGB, PSAP | ACHE 1362/4885GPR84 1712/4885FFAR1 3481/4885 |
| US-20250163112-A1 | Porous Body and Method for Producing Same | PSAP, SPPL2B, SDCBP | ACHE 4589/4885GPR84 1114/4885FFAR1 2331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.